ABSTRACT
The incidence of invasive fungal disease has dramatically increased over the past few decades corresponding to the rising number of immunocompromised patients. The major risk factors for severe fungal disease include administration of broadspectrum antibiotics, corticosteroids and cytotoxic agents, invasive medical procedures, and Human Immunodeficiency Virus (HIV) infection. Invasive fungal infections often affect multiple organs, and involvement of the myocardium frequently occurs in disseminated disease. Premortem diagnosis of fungal myocarditis is difficult since clinical findings of myocardial involvement are often absent or ambiguous and blood cultures are often negative. The major fungal pathogens responsible for myocardial infection and the clinical settings in which they occur are reviewed.
INTRODUCTION
Fungal myocarditis generally occurs in the setting of a disseminated fungal infection. For the purposes of this review, fungal myocarditis is defined as the presence of fungal organisms within the myocardium with or without inflammation. Disseminated fungal infections are often extremely difficult to diagnose. This difficulty is best demonstrated by data from studies on fungal endocarditis, an intravascular infection, where blood cultures are positive in only 53% of patients and delayed or incorrect diagnosis occurs in 82% of patients (1). Fungal myocarditis is frequently only detected at autopsy. No prospective investigations have been performed to determine the incidence of myocarditis during fungemia. The data has been derived from analyses of autopsy studies and case reports and the data indicates that fungal myocarditis is a common complication of disseminated fungal infection.
Severe fungal disease typically occurs in the setting of significant immune dysfunction. In the 1950s, physicians began to note an increase in the incidence of fungal diseases, particularly in patients with cancer (2-5). In 1953, Craig and Farber reported that fungal disease was not detected in autopsies of cancer patients at their institution prior to 1946 before the use of chemotherapy, whereas disseminated fungal disease was present in 13 (7.4%) of 175 children with leukemia who had received cytotoxic and hormonal therapies (2).
In 1955, Zimmerman recognized that candidiasis, aspergillosis, cryptococcosis, and mucormycosis, which rarely occurred in healthy individuals, were causing significant disease in patients with cancer and that these mycoses were significantly associated with the use of chemotherapy (3). In 1962, Baker specifically identified leukopenia as the primary predisposing factor for fatal outcomes in mycoses in patients with cancer (6).
Routine use of broad-spectrum antibiotics, corticosteroid administration, increased rates of abdominal and cardiac surgery, intravenous drug abuse, and frequent use of invasive catheters further increased the susceptibility of patients to fungal pathogens. In 1950, Zimmerman suggested that antibiotic use predisposed patients to disseminated fungal disease (7). This observation was confirmed by other clinicians (8-18).
Corticosteroid therapy was also identified as a major predisposing factor for severe fungal disease (11, 14, 15, (18) (19) (20) (21) (22) . Primary metabolic disorders, such as Cushing's syndrome and diabetes mellitus, were also determined to be important predisposing conditions (15, 23) .
Additionally, intravenous drug use (24-29), surgery (15, 28, 30, 31), and indwelling vascular catheters (15, 32) were identified as an important risk factors for severe fungal infections.
The epidemic from HIV has resulted in unprecedented numbers of immunocompromised individuals. Disseminated fungal infections occur relatively frequently in individuals with advanced HIV disease. For example, crytococcosis occurs in 6-8% of patients with HIV in the USA (33, 34) and up to 30% in these patients in underdeveloped countries (35, 36) . Patients with advanced HIV disease are also at significant risk for severe infections due to Candida, Aspergillus, Histoplasmosis, Coccidioides, and Blastomycosis (37-41).
FUNGAL MYOCARDITIS
Prior to the 1950s, fungal myocarditis was rarely reported. In a 1942 literature review of myocarditis, Saphir identified only 20 cases due to fungi (42). In 1947, Gore and Saphir published an analysis of 1,402 autopsies with confirmed myocarditis and identified fungal myocardial infection in 14 (1%) patients (43). In a review of all autopsies performed at The Johns Hopkins Hospital from 1889 through 1977, Walsh et al identified 34 patients with fungal myocarditis, and all cases occurred after 1954 (44).
An association with fungal myocarditis and cancer, particularly hematological malignancies, was recognized by several investigators in the 1960s (5, 45). In an autopsy study of 420 hearts from patients with acute leukemia, Roberts et al found a 2.4% rate of fungal myocarditis which accounted for 32% of the total cardiac infections (45). Additional investigations of cancer patients identified antineoplastic drugs, antibiotics, corticosteroids, diabetes mellitus, indwelling catheters, and major surgery (particularly gastrointestinal surgery) as important risk factors for fungal myocardial disease (44, 46-48).
Autopsy series and reviews indicate that the prevalence of cardiac disease in patients with HIV ranges from 25-75%, with myocarditis identified in approximately half of these individuals (49-51). However, a specific etiology is determined in less than 20% of the cases of myocarditis. The incidence of myocarditis due to fungi ranges from 0 to approximately 20% (51-71). The patients identified with fungal myocardial infection all had advanced HIV disease.
Candida
Candida is the most prevalent cause of fungal myocarditis. Incidence rates for myocarditis in the setting of disseminated candidiasis range from approximately 10% (21, 72) to over 60% (30, (73) (74) (75) . Prior to the routine use of cytotoxic and immunosuppressive medications, reports of myocardial involvement with candidiasis were uncommon (7, 10, 12, 24, [76] [77] [78] [79] [80] [81] [82] . In a 1947 review of 1,402 pathologically confirmed cases of myocarditis, Gore and Safir found no cases of candidal involvement of the heart (43). In the 1950s, clinicians recognized the association of chemotherapeutically induced neutropenia with candidiasis (2, 3, 5, 6, 72). However, increased rates of Candida sepsis were first well documented in the 1960s (17, 83). The increased focus on mycotic infections in cancer patients led to careful autopsy studies that identified a significant incidence of cardiac candidiasis in these patients (5, 72). In an autopsy report of the hearts of 420 patients with acute leukemia in 1968, Roberts et al described 6 (1.4%) patients with Candida myocarditis (45). In a 1978 study of 85 cancer patients with disseminated candidal infections, Ihde et al identified 17 (20%) patients with Candida myocarditis (46).
Eight patients had myocardial abscesses that were grossly visible. Additional metastatic foci of infection with Candida were detected in all patients, with abscesses occurring in the kidneys, gastrointestinal tract, lungs, liver and central nervous system in the majority of patients. Microscopically, Candida myocardial abscesses are characterized by the presence of numerous pseudohyphal and yeast forms involving tissue with central zones of necrotic myocytes and mononuclear infiltrates (5, 45, 46, 72, 75, 82) . However, the extent of the inflammatory reaction varied according to the immune status of the patient, with the absence of neutrophils and dense fungal growth occurring in patients receiving high doses of cytotoxic or immunosuppressive agents compared to intense inflammatory reactions with few organisms in patients not receiving these medications (44, 75).
In 1972, Bernhardt et al reported that disseminated candidiasis in surgical patients resulted in myocardial infection in 13 of 14 patients who were autopsied during a 2 year period (30). Of the patients with myocarditis, all of the patients had central venous catheters, twelve of the patients underwent major surgical procedures, and all received multiple antibiotics. Five of the patients had positive premortem blood cultures. The myocardium was the most frequently involved organ, followed by the kidney and brain. The eye was involved in 5 cases. Notably, this paper was the first to identify ocular involvement as a manifestation of systemic candidal disease and advocated fundiscopic examination in patients suspected of disseminated candidiasis (30).
In a review of autopsies from 1959 to 1974, Frankin et al identified 50 patients with systemic candidiasis and detected Candida myocarditis in 31 (62%) of the patients (75) . Gross myocardial lesions were evident in 7 patients. Histological evaluations of the hearts revealed myocardial abscesses which varied in size and number and the inflammatory reactions ranged from complete lack of inflammation to acute suppuration with coagulative necrosis of myocytes. The distribution of the abscesses was random, which is consistent with seeding secondary to disseminated disease. All of the patients had significant medical illnesses including malignancy, autoimmune disorders, and bacterial infections. Half of the patients had undergone recent surgical procedures, 11 of which were major operations. Administration of antibacterial agents occurred in 27 of the 31 patients, antineoplastic drugs were given to 9, and 16 were receiving corticosteroids. 75, 85) . The frequency at which ECG changes occur is not significantly different from that in other critically ill patients with or without myocarditis, or even from patients with disseminated candidiasis without cardiac infection (46, 75, 110). In the 31 patients with myocarditis described by Franklin et al, ECG evidence of conduction disturbances was seen in 10 patients, supraventricular arrhythmias in 5, QRS abnormalities consistent with myocardial infarction in 3, and significant T wave abnormalities in 13 (75) . Van Kirk et al describe a case of complete atrioventricular block in a patient with acute myelomonocytic leukemia were C. albicans microabscesses where found in the His bundle (111). Pseudohyphal invasion of the conduction system can also occur (75) . Additionally, Candida invasion of blood vessels resulting in infarction of myocardium has been described (75).
Aspergillus
Invasive aspergillosis usually occurs in immunocompromised patients and is associated with a high mortality rate (112) . In a recent review of invasive . In a manner similar to the rise in rates of candidiasis, the increased incidence of invasive aspergillosis corresponds to the more frequent use of chemotherapeutics, immunomodulators, broad-spectrum antibiotics, and invasive procedures (3, 5, 21, 45, 72, 107, 113, 136) . In 1962, Baker recognized that leukopenia was the primary predisposing factor for fatal aspergillosis (6).
As cancer therapy became more intensive, prolonged granulocytopenia was identified as the major risk factor for invasive aspergillosis (21, 165). By the early 1980s, concern for the increased incidence of severe fungal disease, particularly aspergillosis, in cancer patients resulted in the advocation of empiric antifungal therapy in persistently febrile neutropenics (166) .
In 1970, Young et al described the spectrum of aspergillosis in 98 patients with significant underlying illnesses, primarily leukemia, and identified 5 (5%) patients with myocardial infection (107). Although two patients had a few, small (1 to 3 mm) abscesses that the authors deemed clinically insignificant, three patients had severe disease characterized by both small and large abscesses with extensive invasion of adjacent myocardium by Aspergillus.
The typical histologic appearance of Aspergillus myocardial infection is abscesses containing septated hyphae associated with necrosis and infarction ( Figure 1) (44, 120, 126, 167) . The abscesses may be either focal or diffuse. Mycotic thrombosis of cardiac vessels is common, which is consistent with the predilection of the fungus for vascular structures.
A neutrophilic inflammatory response is commonly seen, however this may be absent in the setting of severe neutropenia (44).
Hyphae often extend though the thrombosed vessels into the necrotic myocardium (107, 147, 167). In 1974, Willliams described 2 patients with Aspergillus myocarditis and reviewed 37 cases reported in the literature (167) . Risk factors identified included debilitating diseases, cytotoxic drugs, immunosuppressive drugs, steroids, radiation, leucopenia, and antibiotics. Blood cultures for Aspergillus were positive in one of the 39 patients. An additional patient had a positive urine culture for Aspergillus and another had a positive sputum culture. Aspergillosis was the suspected cause of death in the majority of patients, but the extent to which myocarditis contributed to death was unclear, since extensive necrotizing pneumonia and cerebral abscesses were common.
Aspergillus is the second most common cause of fungal endocarditis (1) and the second most common fungal etiology of postoperative endocarditis (28, 47, 89 Risk factors for aspergillosis included chemotherapy, broad-spectrum antibiotics, corticosteroids, cardiac surgery, and renal disease. Three patients had positive premortem blood cultures for Aspergillus.
Of the 16 patients with Aspergillus myocarditis, the myocardium was solely involved in 10 cases, the myocardium and endocardium in 5, the myocardium and pericardium in 2, and pancarditis in 1. There were two additional cases of cardiac aspergillosis, 1 involving only the pericardium and 1 the endocardium.
Patients with AIDS are at significantly increased risk for invasive aspergillosis (37, 38, 40, 113). However, there are relatively few reports of Aspergillus myocarditis in patients with AIDS (64, 66, 68, 100, 143, 153, 154, 156, 170) . In a 1992 review of invasive aspergillosis in patients with AIDS, Minamoto et al identified myocardial infection in 5 (14%) of 37 cases (170) . Infection of the myocardium by Aspergillus typically occurs by direct extension, usually from the lung. Aspergillus invades the pulmonary vessels, ascends to infect the endocardium and subsequently involves the myocardium (97, 98, 107, 116).
As described in Zimmerman's report of the first identified case of Aspegillus endocarditis (7), infected cardiac valves are also a common point of origin for subsequent myocardial invasion. Myocarditis also occurs following seeding during fungemia (107). As in the case of Candida myocarditis, Aspergillus mural endocardial or pericardial infection can occur secondary to hyphal invasion from or rupture of myocardial abscesses established by hematogenous seeding (44, 97, 98, 114, 141, 164).
Despite the extensive necrosis and infarction that frequently accompany cardiac aspergillosis, ECG findings are often absent or nonspecific (107, 167). In Williams' review, 6 (15%) of 39 patients had electrocardiographic changes consistent with ischemia or infarction (167) . Aspergillus myocarditis has been identified in patients who died due to complications of arrhythmias and congestive heart failure (129) . Lethal infarctions secondary to direct extension of myocardial abscesses into major cardiac vessels or by embolic seeding of the coronary vessels with subsequent thrombosis and invasion of myocardial tissue have been documented (144, 151) .
Cases where Aspergillus myocarditis involved the conduction system resulting in heart block and death have also been described (151, 171) .
In the majority of cases of Aspergillus myocarditis, the species was not identified. However when speciation was performed, A. fumigatus was most commonly identified (Gerkin, 1950 #168)(1, 28, 66, 121, 122, 131, 138, 147, 148, 154, 156, 157, 161, 164, 167) . Although a rare cause of disease, A. terres has been the etiologic agent of myocarditis in 7 patients reported in the literature (127, 137, 140, 146, 149, 152) . Multi-organ involvement occurred in all patients with A. terres myocarditis, and concomitant endocarditis is typical. All cases of A. terres myocarditis occurred after cardiac valve surgery or in immunosuppressed patients. Additionally, several cases of myocardial infection with A. flavus have been reported (117, 125, 142, 147, 167, 171) .
Cryptococcus neoformans
Prior to 1981, cryptococcal infections were uncommon, with less than 1,000 cases reported in the United States (172) . In the 1950s, C. neoformans became identified as an opportunistic pathogen, particularly causing disease in the setting of steroid use (11, 173, 174) or in patients with lymphoproliferative disorders (175, 176) . With the onset of the AIDS epidemic, C. neoformans became the most common cause of culture-positive meningitis in adults in New York City (33, 177). In the United States, 5-10% of patients with AIDS develop cryptococcosis (33, 34).
In immunocompromised individuals, C. neoformans primarily causes a lifethreatening menigo-encephalitis, and dissemination is common.
In 1956, Littman and Zimmerman first documented C. neoformans myocarditis in a patient with sarcoma and cryptococcosis (178) . In 1962, Hutter and Collins identified 2 cancer patients with cryptococcal cardiac involvement (5). In 1965, Jones et al described a patient with C. neoformans myocarditis who developed a cardiomyopathy that resulted in congestive heart failure, heart block, and death (179) (Figure 2) . Foci of myocardial cell necrosis may be present. Although overt cardiac manifestations were infrequently seen in AIDS patients with myocarditis (66, 99), ECG abnormalities and congestive heart failure associated with a fatal outcome has been described (185).
Coccidioides immitis
Symptomatic disseminated disease occurs in 0.5% of people infected with C. immitis, which is an endemic dimorphic fungus found in the lower Sonoran life zone of the Americas, which in the US corresponds to the southwestern states (186) . Although severe coccidioidomycosis is more common in patients with immunodeficiencies, dissemination can occur in immunocompetent hosts (186) . Autopsy studies indicate that 9 to 28% of patients with disseminated coccidioidomycosis have myocarditis (43, 187, 188). There are numerous cases reported of disseminated infection with spherules identified in the myocardium (43, 104, (187) (188) (189) (190) (191) (192) (193) (194) (195) . Myocardial abscesses are characterized by central zones of necrosis containing spherules both inside and outside of multinucleated giant cells accompanied by a diffuse interstitial mononuclear cell infiltrate (104, 188). Of note, organisms are not always found in the inflammatory lesions (188, 190) . Patients with AIDS are at high risk for hematogenous disseminated infection from C. immitis (37, 38, 196) and spherules have been identified in the myocardium of patients with AIDS (197) . C. immitis is an uncommon cause of fungal endocarditis which may involve the mural endocardium and the underlying myocardium (188, 191) . Also in endocarditis, myocardial infection can occur due to hematogenous seeding of the organism (191) .
Dyspnea and non-specific ECG abnormalities have been reported in myocarditis (188) , but these findings are also common in patients with primary pulmonary coccidioidomycosis (187, 198) . Symptomatic concomitant pericarditis can occur due to rupture of myocardial abscesses into the pericardial space (187, 188, 194) .
Histoplasma capsulatum
The dimorphic fungus Histoplasma capsulatum var. capsulatum is the most prevalent cause of fungal respiratory infections, infecting approximately 500,000 individuals in the USA each year (199, 200 (191, 207, 208) . Histoplasma granulomas typically contain numerous macrophages filled with yeast cells and have substantial destruction of adjacent myocytes (207) . However, in the setting of AIDS, histocytes with intracellular yeast cells may be present between myocardial fibers with minimal inflammation and without granuloma formation (60, 70). Clinically, H. capsulatum myocarditis is usually silent; however nonspecific ECG changes and cardiomegaly can occur (209) 
Blastomyces dermatitidis
Blastomyces dermatitidis is an endemic dimorphic fungus most prevalent in the midwest and southcentral US. In 1904, Cleary reported a case of disseminated Blastomyces dermatitidis where fungal cells were identified in the patient's myocardium (210) . Since then many cases of myocardial infection due to hematogenous seeding have been reported (42, 43, 211-217). B. dermatitidis endocarditis secondary to direct extension from a pulmonary or mediastinal blastomycotic lesion have been described with associated myocardial abscesses (211, 214, 216) . Advanced HIV infection may predispose to severe blastomycosis (218) 
Zygomycetes
Fungi of the Order Zygomycetes are uncommon causes of invasive, life-threatening mycoses that characteristically occur in severely immunocompromised individuals or in patients with diabetic ketoacidosis (220) . Myocardial infections most often occur in patients undergoing treatment for cancer, particularly leukemia and lymphoma (3, 11, 21, 45, 221-223).
Myocardial zygomycosis has also been described in patients with extensive burns (224, 225) and following abdominal surgery (18). Disseminated disease frequently involves multiple organs (223) . The pathogenesis of myocardial zygomycosis is by direct extension from adjacent foci of infection (98) or via hematogenous seeding (223) . The myocardium is often diffusely infected (223) . In only one case was the Zygomycetes responsible for myocardial infection speciated, Cunninghamella bertholletiae (226) . Zygomycetes have a propensity to invade blood vessels (225) .
Cardiac infection has been associated with thrombosis of coronary arteries and subsequent hyphal invasion through the walls of vessels resulting in myocardial infarction (3, 11, 104, 223, 225, 226).
Phaeohyphomycoses
Disseminated phaeohyphomycoses are uncommon infections due to dematiaceous or pigmented (melanized) filamentous fungi.
In a recent literature review of disseminated phaeohyphomycosis, Revankar et al reported that cardiac infection occurred in 25 of 72 patients, with myocardial involvement in 14 (19%) cases (227) . Malignancy (47, 228-233) and organ transplantation (227, 234, 235) were common risk factors for invasive disease. Myocardial phaeohyphomycosis has occurred in a patient with AIDS (230), following cardiac surgery (236) , and in a premature infant (237) . Although no specific clinical information was provided, Atkinson et al identified 7 patients with cardiac phaeohyphomycosis (47). Six patients had myocardial involvement, with the myocardium solely involved in 3 patients, myocardium and endocardium in 1, and pericardium and myocardium in 2. Myocardial involvement was characterized by the presence of numberous dark hyphae with chlamydoconidia with extensive necrosis and vascular invasion (234) . Species identified in cases of myocardial infection included Scedosporium prolificans (229) (230) (231) (232) (233) 235) , Myceliophthora thermophilia (228) , Exophiala jeanselmei (236) , Bipolaris specifera (227, 234) , and Bipolaris species (237).
Fusarium
Fusarium species rarely cause systemic disease, and are only pathogenic in the setting of severe immune dysfunction (238) . Myocardial infection has been reported in patients with severe burns (239), during treatment for lymphoma (240) , and following bone marrow transplantation (241, 242) . All cases of myocardial infection have occurred in patients with multi-organ infection.
Numerous myocardial microabcesses are commonly identified with prominent fungal angioinvasion (241, 242) . Fusarium species identified in these patients include F. moniliforme (240, 241) and F. oxysporum (242) .
Trichosporon beigelli (cutaneum)
Trichosporon beigelli (cutaneum) is a frequent cause of superficial mycotic infection and also associated with invasive disease in significantly immunosuppressed hosts (243) (244) (245) . Disseminated multiorgan infection (82%) is the most common form of invasive disease, which includes frequent infection of the heart (244). Disseminated disease with myocardial abscesses most often occurs in patients with acute leukemia (245) (246) (247) (248) (249) (250) (251) (252) . Myocardial infection has also been reported during immunosuppressive therapy (253) . Myocardial abscesses consist of necrotic tissue with dense masses of hyphae and yeast cells and varying amounts of inflammatory cells in surrounding tissue (248 (Walsh, 1986 #349))(251).
Blastoschizomyces capitatus
Blastoschizomyces capitatus is a member of the Phyllum Ascomycota that until recently was considered to be in the Phyllum Basidiomycota and was formerly identified as T. captitatum. B. capitatus is an emerging opportunistic fungus in immunosuppressed patients (254) . Myocardial infection during disseminated disease has been demonstrated in patients undergoing bone marrow transplantation (255, 256) or chemotherapy for leukemia (257, 258) . Myocardial abscesses are characterized by the presence of pleomorphic yeast-like cells and septate hyphae with myocardial necrosis. Hyphae may also have affinity for vessel walls (258).
CONCLUSIONS
Invasive fungal disease became increasingly common in the second half of the 20 th century. In particular, the incidence of serious candidal infections has risen dramatically (259) and Candida sp. are currently responsible for nearly 8% of nosocomial bloodstream infections (260) . Candida sp. are a major cause of morbiditity and mortality, particularly in premature infants, patients infected with HIV and neutropenic patients (39, [261] [262] [263] [264] [265] . Mortality rates of 39% in neonates (266) and 38% in patients with AIDS (39) have recently been reported.
The use of intensive cytotoxic and immunosuppressive therapies for malignancies and organ transplants has substantially increased and the incidence of fungal disease has similarly risen (267) (268) (269) (270) . Prior to the modern use of chemotherapy, less than 5% of patients with hematological malignancies died of fungal infection compared to more recent reports of death rates of 40% or higher (271) . Severe fungal infections now occur in up to 50% of bone marrow transplant patients and 10% of solid organ transplant recipients (272) . In neutropenic patients, as many as 40% of fungal infections are disseminated and more than 70% of these mycoses are fatal (262) . At present, antimicrobial use continues to have tremendous impact on the epidemiology of nosocomial infections, including fungal disease (273) . Catheters, particularly central venous catheters, continue to be a major source of entry for fungal pathogens, particularly Candida (264, 266, 273, 274) , and recent data suggest that the use of heparin to maintain patency of catheters may significantly enhance the pathogenicity of Candida (275).
The reviewed data indicate that a significant number of individuals with disseminated fungal disease will develop myocardial infection. However, invasive fungal diseases are frequently difficult to diagnose. Routine microbiological testing often fails to identify fungal pathogens. For some pathogens, such as H. capsulatum, serological testing may facilitate proper diagnosis (276, 277) . Although not routinely available, molecular methods such as PCR for detecting DNA from clinical specimens are being developed (278) (279) (280) (281) (282) (283) (284) (285) (286) (287) (288) (289) (290) . Myocardial involvement is often clinically silent. Clinical symptoms of dyspnea usually are attributable to concomitant pulmonary infection.
In general, ECG findings are not helpful in determining whether there is myocardial infection (110). Similarly, endomyocardial biopsy is insensitive (291, 292) . Nevertheless, if a patient mounts an inflammatory response in the cardiac tissues, analysis of the infiltrating cell type in the myocardium may be helpful. In most cases of infectious myocarditis, Tlymphocytes and macrophages predominate, whereas neutrophils and macrophages are more common in fungal myocarditis (292) .
Echocardiography, particularly, transesophageal echocardiography, has had some success in diagnosing fungal myocarditis when endocardial abnormalities were present (143, 158, 162, 293) . Magnetic resonance(MR) imaging, particularly using spin echo, cine MR angiography and contrast enhanced spin echo imaging, has been used to identify the presence of myocarditis (294) (295) (296) (297) .
MR imaging may be helpful in diagnosing myocarditis in the setting of disseminated fungal disease with signs or symptoms of disturbed cardiac function.
In order to better define the current incidence of myocardial infection by fungi, prospective investigations examining rates of dissemination, clinical findings, and outcomes are necessary. Although new methods for diagnosing fungal infections by microbiological and radiographic methods are being investigated, diagnosis of fungal disease remains problematic. Unsuspected fungal infections are often detected during autopsy (160) . This is in agreement with publications noting that clinical and autopsy diagnoses can differ by over 44% (298, 299) . However, autopsy rates have significantly declined (300) to rates of around 9% for most hospitals, and many hospitals have autopsy rates at 0% (301) . Autopsy studies can assist in defining the pathogenesis of fungal infection (ie. hematogenous or contiguous spread) and continue to play an important role in identifying fungal disease.
Given the increased risk of fungal infection, standard clinical practice empirically employs antifungal therapy in febrile immunocompromised individuals unresponsive to antibacterial drugs (302) (303) (304) (305) (306) . Current clinical practice dictates that all candidemias should be treated since this pathogen frequently causes metastatic disease (261) .
Additionally, primary prophylaxis is standard in the management of immunosuppressed oncology patients (304) . Prophylactic antifungal therapy directed against Candida also decreases the incidence of serious candidiasis in premature infants (307) and in patients with AIDS (303, (308) (309) (310) (311) . Although costly, the introduction of liposomal amphotericin, with its reduced nephrotoxicity and infusion-related reactions, has improved our ability to treat certain patients with invasive fungal disease (312) . The first available pneumocandin, Caspofungin, which inhibits the synthesis of the 1,3-beta-D-glucan component of the cell wall in diverse pathogenic fungi, may increase our ability to treat fungal infections (313, 314) . Voriconizole, a second-generation triazole, is currently in phase III clinical trials and has recently been shown to be comparable with amphotericin B preparations for the empirical treatment of febrile neutropenics (315) and effective in the primary treatment of invasive pulmonary aspergillosis (316) . Better treatment regimens and more rapid institution of antifungal therapy may reduce the incidence and improve the outcome of disseminated fungal disease.
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